Skip to main content

FreeCME
About Us
Sign Up|Log In

FreeCME
About Us
All Products

Sign Up|Log In

Browse by Speciality Area

Hospital Management
Cardiology
Critical Care
Emergency Medicine
Infectious Disease
Integrative Medicine
Internal Medicine
Neurology
Obstetrics/Gynecology
Primary Care/Hospitalist

Browse by Product Type

Subscription Publications
Books & Study Guides

All Access Subscription

Get unlimited access to our full publication and article library.

Interested in Group Sales? Learn more

Home
Drug Formulary Review Archives
December 1, 2001

Drug Criteria & Outcomes: Ticlid/Plavix formulary evaluation

December 1, 2001

Issue Date: December 1, 2001

Table of Contents

Be prepared: Anthrax outbreaks may not remain isolated acts, experts say
Mayo Clinic develops rapid anthrax test
Drugs may reduce kidney risk in diabetics
Is politics a part of ACEs’ exclusion from studies?
Program: 24x7 pharmacist call center support
News Briefs: JAMA: Older antibiotics trump newer ones
News Briefs: Black-box warning added to Xeloda label
News Briefs: Centocor issues warning about Remicade
News Briefs: ‘Smart bomb’ drugs show promise against cancers
News Briefs: Consumers fear vaccine shortage this season
Drug Criteria & Outcomes: Ticlid/Plavix formulary evaluation
Drug Criteria & Outcomes: In the Pipeline
Drug Criteria & Outcomes: New FDA Approvals

Financial Disclosure: None of the authors or planners for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients

Shop Now: Search Products

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements

Emergency
Hospital
Clinical
All Access
Help
Search
About Us
Newsletters
FreeCME

The trusted source for healthcare information and CONTINUING EDUCATION.

ACCOUNTS RECEIVABLE

MAILING ADDRESS

1010 Sync St., Suite 100

Morrisville, NC 27560-5468

USA

© 2025 Relias. All rights reserved.

Do Not Sell My Personal Information
Privacy Policy
Terms Of Use
Help
Group Sales

For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

We use cookies to create a better experience. By continuing to use our site, you consent to the use of cookies outlined in our Privacy Policy.

Close Banner